Medical abortion in the first trimester: The use of serum hCG and endometrial thickness as markers of completeness

European Journal of Contraception and Reproductive Health Care

Volumn 12, Issue 4, 2007, Pages 366-371

  Parashar, Pooja ^a   Iversen, Ole Erik ^a   Midbøe, Grete ^a   Myking, Ole ^a   Bjørge, Line ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Human chorionic gonadotrophin (hCG); Medical abortion; Mifepristone; Misoprostol; Ultrasound

Indexed keywords

CHORIONIC GONADOTROPIN; MIFEPRISTONE; MISOPROSTOL;

ADULT; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; ECHOGRAPHY; ENDOMETRIUM; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THERAPEUTIC ABORTION; VACUUM ASPIRATION;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADOLESCENT; ADULT; CHORIONIC GONADOTROPIN; ENDOMETRIUM; FEMALE; HUMANS; MIDDLE AGED; MIFEPRISTONE; MISOPROSTOL; NORWAY; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 36348929486     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.1080/13625180701536300     Document Type: Article

References (15)

1. Arisi E. Changing attitudes towards abortion in Europe. Eur J Contracept Reprod Health Care 2003;8:109-21.
2. Bjørge L, Johnsen SL, Midbøe G, et al. Early pregnancy termination with mifepristone and misoprostol in Norway. Acta Obstet Gynecol Scand 2001;80:1056-61.
3. WHO Task Force. WHO Task Force on Post-ovulatory Methods of Fertility Regulation. Termination of pregnancies with reduced doses of mifepristone. BMJ 1993;307:532-7.
4. Christin-Maitre S, Bouchard P, Spitz IM. Medical termination of pregnancy. N Engl J Med 2000;342:946-56.
5. Cowett AA, Cohen LS, Lichtenberg ES, et al. Ultrasound evaluation of the endometrium after medical termination of pregnancy. Obstet Gynecol 2004;103:871-5.
6. Acharya G, Haugen M, Bra° then A, et al. Role of routine ultrasonography in monitoring the outcome of medical abortions in a clinical setting. Acta Obstet Gynecol Scand 2004;83:390-4.
7. Rorbye C, Norgaard M, Nilas L. Prediction of late failure after medical abortion from serial beta-hCG measurements and ultrasonography. Hum Reprod 2004;19:85-9.
8. Pastorfide GB, Goldstein DP, Kosasa TS, et al. Serum chorionic gonadotropin activity after molar pregnancy, therapeutic abortion, early term delivery. Am J Obstet Gynecol 1990;76:788-91.
9. Lähteenmäki P. The disappearance of hCG and return of pituitary function after abortion. Clin Endocrinol 1978;9:101-12.
10. Marrs RP, Kletzky OA, Howard WF, et al. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion. Am J Obstet Gynecol 1979;135:731-6.
11. Steier JA, Bergsjø P, Myking OL. Human chorionic gonadotropin in maternal plasma after induced abortion, spontaneous abortion and removed ectopic pregnancy. Obstet Gynecol 1984;64:391-4.
12. Barnhart K, Sammel MD, Chung K, et al. Decline of serum human chorionic gonadotropin and spontaneous complete abortion: defining the normal curve. Obstet Gynecol 2004;104:975-81.
13. Harwood B, Meckstroth KR, Mishell DR Jr, et al. Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortion. Contraception 2001;63:255-6.
14. Honkanen H, Ranta S, Ylikorkala O, et al. The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy. Hum Reprod 2002;17:2315-9.
15. Walker K, Schaff E, Fielding S, et al. Monitoring serum chorionic gonadotropin levels after mifepristone abortion. Contraception 2001;64:271-3.